Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H15N3O4 |
Molecular Weight | 313.308 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCN1C(=O)C2=CC=CC3=C2C(=CC(=C3)[N+]([O-])=O)C1=O
InChI
InChIKey=XXVLKDRPHSFIIB-UHFFFAOYSA-N
InChI=1S/C16H15N3O4/c1-17(2)6-7-18-15(20)12-5-3-4-10-8-11(19(22)23)9-13(14(10)12)16(18)21/h3-5,8-9H,6-7H2,1-2H3
Molecular Formula | C16H15N3O4 |
Molecular Weight | 313.308 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Mitonafide is a nitro-containing antitumor drug. Mitonafide participated in clinical trials phase II in colorectal cancer patients, however, the results have shown that the drug was not active and induced severe myelotoxicity. Besides, the drug was involved in phase II for the patients with non-small cell lung cancer (NSCLC), where it was not active in spite of the safe administration. Information about the current development of this drug is not available.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8913845
All but one received a 120-hour (5-day) continuous infusion of Mitonafide at a starting dose of 200 mg/m2/day every 3 weeks
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:31:39 GMT 2023
by
admin
on
Sat Dec 16 17:31:39 GMT 2023
|
Record UNII |
06Q0V17SI9
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C582
Created by
admin on Sat Dec 16 17:31:39 GMT 2023 , Edited by admin on Sat Dec 16 17:31:39 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID90203321
Created by
admin on Sat Dec 16 17:31:39 GMT 2023 , Edited by admin on Sat Dec 16 17:31:39 GMT 2023
|
PRIMARY | |||
|
100000080879
Created by
admin on Sat Dec 16 17:31:39 GMT 2023 , Edited by admin on Sat Dec 16 17:31:39 GMT 2023
|
PRIMARY | |||
|
C019215
Created by
admin on Sat Dec 16 17:31:39 GMT 2023 , Edited by admin on Sat Dec 16 17:31:39 GMT 2023
|
PRIMARY | |||
|
06Q0V17SI9
Created by
admin on Sat Dec 16 17:31:39 GMT 2023 , Edited by admin on Sat Dec 16 17:31:39 GMT 2023
|
PRIMARY | |||
|
327044
Created by
admin on Sat Dec 16 17:31:39 GMT 2023 , Edited by admin on Sat Dec 16 17:31:39 GMT 2023
|
PRIMARY | |||
|
CHEMBL43482
Created by
admin on Sat Dec 16 17:31:39 GMT 2023 , Edited by admin on Sat Dec 16 17:31:39 GMT 2023
|
PRIMARY | |||
|
4574
Created by
admin on Sat Dec 16 17:31:39 GMT 2023 , Edited by admin on Sat Dec 16 17:31:39 GMT 2023
|
PRIMARY | |||
|
SUB09007MIG
Created by
admin on Sat Dec 16 17:31:39 GMT 2023 , Edited by admin on Sat Dec 16 17:31:39 GMT 2023
|
PRIMARY | |||
|
C66165
Created by
admin on Sat Dec 16 17:31:39 GMT 2023 , Edited by admin on Sat Dec 16 17:31:39 GMT 2023
|
PRIMARY | |||
|
300288
Created by
admin on Sat Dec 16 17:31:39 GMT 2023 , Edited by admin on Sat Dec 16 17:31:39 GMT 2023
|
PRIMARY | |||
|
54824-17-8
Created by
admin on Sat Dec 16 17:31:39 GMT 2023 , Edited by admin on Sat Dec 16 17:31:39 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |